Skip to main content
Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
Published Web Location
http://europepmc.org/articles/PMC3786091?pdf=renderNo data is associated with this publication.
Abstract
Heart rate is an important contributor in the pathophysiology of both coronary artery disease (CAD) and heart failure (HF). Ivabradine is an anti-anginal and anti-ischaemic agent, which selectively and specifically inhibits the I f current in the sino-atri
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.